[1]
|
徐谭, 刘如平, 袁俊强, 等. 急性冠状动脉综合征患者经皮冠状动脉介入术后平均血小板容积对近期预后的影响[J]. 中国动脉硬化杂志, 2020, 28(7): 599-603.
|
[2]
|
王顺楷, 方志敏, 刘顺民, 等. 循环microRNA-126在急性冠脉综合征患者中的表达差异[J]. 世界最新医学信息文摘, 2019, 19(91): 27+30.
|
[3]
|
方子寒, 谢盈彧, 张军平. 急性冠状动脉综合征中医诊治概述[J]. 中华中医药学刊, 2019, 37(8): 1852-1855.
|
[4]
|
Moreno, P.R., Purushothaman, K.R., Fuster, V., et al. (2002) Intimomedial Interface Damage and Adventitial Inflammation Is Increased beneath Disrupted Atherosclerosis in the Aorta: Implications for Plaque Vulnerability. Circulation, 105, 2504-2511. https://doi.org/10.1161/01.CIR.0000017265.52501.37
|
[5]
|
Lairez, O. and Hyafil, F. (2020) A Clinical Role of PET in Atherosclerosis and Vulnerable Plaques? Seminars in Nuclear Medicine, 50, 311-318. https://doi.org/10.1053/j.semnuclmed.2020.02.017
|
[6]
|
徐成斌. 急性冠脉综合征的病理与病理生理学[J]. 中国医刊, 2001, 36(11): 7-9.
|
[7]
|
Cholette, J.M., Blumberg, N., Phipps, R.P., et al. (2008) Developmental Changes in Soluble CD40 Ligand. The Journal of Pediatrics, 152, 50-54. https://doi.org/10.1016/j.jpeds.2007.06.036
|
[8]
|
Geldart, T. and Illidge, T. (2005) Anti-CD40 Monoclonal Antibody. Leukemia & Lymphoma, 46, 1105-1113.
https://doi.org/10.1080/10428190500085255
|
[9]
|
杜振兰. CD40-CD40L共刺激途径在体液免疫和细胞免疫中的作用[J]. 细胞与分子免疫学杂志, 2012, 28(12): 1341-1343.
|
[10]
|
Volker, H., Joseph, R.S., Michael, G., et al. (1998) CD40 Ligand on Activated Platelets Triggers an Inflammatory Reaction of Endothelial Cells. Nature, 391, 591-594. https://doi.org/10.1038/35393
|
[11]
|
Danese, S., Sans, M. and Fiocchi, C. (2004) The CD40/CD40L Costimulatory Pathway in Inflammatory Bowel Disease. Gut, 53, 1035-1043. https://doi.org/10.1136/gut.2003.026278
|
[12]
|
吴辉, 吴伟, 卿立金. CD40/CD40L信号通路与易损斑块关系及中医药干预策略[J]. 中国医师协会中西医结合医师大会, 2011, 23(12): 373-375.
|
[13]
|
Liu, Y.F., Yu, H.M., Zhang, Y., et al. (2008) TLRs Are Important Inflammatory Factors in Atherosclerosis and May Be a Therapeutic Target. Medical Hypotheses, 70, 314-316. https://doi.org/10.1016/j.mehy.2007.05.030
|
[14]
|
Schönbeck, U., Mach, F., Bonnefoy, J.Y., et al. (1997) Ligation of CD40 Activates Interleukin 1beta-Converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1beta. Journal of Biological Chemistry, 272, 19569-19574. https://doi.org/10.1074/jbc.272.31.19569
|
[15]
|
Van, J.M., Da, M.P., Mol, A., et al. (2008) Transendothelial Migration Drives Dissociation of Plateletmonocyte Complexes. Thrombosis and Haemostasis, 100, 271-279. https://doi.org/10.1160/TH08-03-0165
|
[16]
|
Van, L.M., Gijbels, M.J., et al. (2008) Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR-/-mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 84-89.
https://doi.org/10.1161/ATVBAHA.107.154807
|
[17]
|
Soehnlein, O., Zernecke, A., Eriksson, E.E., et al. (2008) Neutrophil Secretion Products Pave the Way for Inflammatory Monocytes. Blood, 112, 1461-1471. https://doi.org/10.1182/blood-2008-02-139634
|
[18]
|
Erbel, C., Sato, K., Meyer, F.B., et al. (2007) Functional Profile of Activated Dendritic Cells in Unstable Atherosclerotic Plaque. Basic Research in Cardiology, 102, 123-132. https://doi.org/10.1007/s00395-006-0636-x
|
[19]
|
朱星. 散结通脉方对动脉粥样硬化大鼠CD40/CD40L信号通路干预的实验研究[D]: [博士学位论文]. 长春: 长春中医药大学, 2019, 204(3): 1246-1352.
|
[20]
|
朱丹, 赵旭颖, 李海啸, 等. 急性脑梗死患者颈动脉斑块与基质金属蛋白酶、血清白介素及多肽生长因子的关系研究[J]. 现代生物医学进展, 2019, 19(18): 3465-3469+545.
|
[21]
|
杨雪娜, 熊咏民. 基质金属蛋白酶在骨关节疾病中的研究进展[J]. 国外医学(医学地理分册), 2019, 40(4): 470-474.
|
[22]
|
Heider, P., Pelisek, J., Poppert, H., et al. (2009) Evaluation of Serum Matrix Metalloproteinases as Biomarkers for Detection of Neurological Symptoms in Carotid Artery Disease. Vascular and Endovascular Surgery, 43, 551-560.
https://doi.org/10.1177/1538574409334826
|
[23]
|
李江, 赵水平, 彭道泉, 等. 冠心病患者血清sCD40L和MMP-9的变化及相关性[J]. 中南大学学报(医学版), 2004, 103(5): 517-520.
|
[24]
|
刘全生, 张雯凌. 可溶性CD40L水平对急性脑梗死患者颈动脉粥样硬化斑块稳定性的影响[J]. 中国实用神经疾病杂志, 2016, 19(7): 12-13.
|
[25]
|
Lee, J.J. (2007) Matrix Metalloproteinases: Influence on Smooth Muscle Cells and Atherosclerotic Plaque Stability. Expert Review of Cardiovascular Therapy, 5, 265-282. https://doi.org/10.1586/14779072.5.2.265
|
[26]
|
刘智敏. 基质金属蛋白酶的结构、功能和调节[J]. 生物医学工程学杂志, 2015(4): 680-683.
|
[27]
|
Duran, C.L., Howell, D.W., Dave, J.M., et al. (2017) Molecular Regulation of Sprouting Angiogenesis. Comprehensive Physiology, 8, 153-235. https://doi.org/10.1002/cphy.c160048
|
[28]
|
Asghar, F., Ali, S., Houman, K., et al. (2019) Therapeutic Targeting of Angiogenesis Molecular Pathways in Angiogenesis-Dependent Diseases. Biomedicine & Pharmacotherapy, 110, 775-785.
https://doi.org/10.1016/j.biopha.2018.12.022
|
[29]
|
Ribatti, D. (2014) The Discovery of Angiogenic Growth Factors: The Contribution of Italian Scientists. Vascular Cell, 6, 162-170. https://doi.org/10.1186/2045-824X-6-8
|
[30]
|
Leroyer, A.S., Pierre-Emmanuel, R., Jean-Sébastien, S., et al. (2008) CD40 Ligand+ Microparticles from Human Atherosclerotic Plaques Stimulate Endothelial Proliferation and Angiogenesis a Potential Mechanism for Intraplaque Neovascularization. Journal of the American College of Cardiology, 52, 1302-1311.
https://doi.org/10.1016/j.jacc.2008.07.032
|
[31]
|
Simonini, A., Moscucci, M., Mulle, D.W.M., et al. (2000) IL-8 Is an Angiogenic Factor in Human Coronary Atherectomy Tissue. Circulation, 101, 1519-1526. https://doi.org/10.1161/01.CIR.101.13.1519
|